Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS: NWBO · Delayed Price · USD
0.388
0.00 (0.08%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of $469.22 million as of July 22, 2024. Its market cap has decreased by -20.49% in one year.
Market Cap
469.22M
Enterprise Value
515.82M
1-Year Change
-20.49%
Ranking
n/a
Category
Stock Price
$0.39
Market Cap Chart
Since December 31, 2001, Northwest Biotherapeutics's market cap has increased from $84.90M to $469.22M, an increase of 452.67%. That is a compound annual growth rate of 7.87%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 467.60M | -42.19% |
Dec 29, 2023 | 808.80M | -2.01% |
Dec 30, 2022 | 825.40M | 27.10% |
Dec 31, 2021 | 649.40M | -41.78% |
Dec 31, 2020 | 1.12B | 789.55% |
Dec 31, 2019 | 125.40M | 17.97% |
Dec 31, 2018 | 106.30M | 40.24% |
Dec 29, 2017 | 75.80M | 75.06% |
Dec 30, 2016 | 43.30M | -85.35% |
Dec 31, 2015 | 295.50M | -11.23% |
Dec 31, 2014 | 332.90M | 129.27% |
Dec 31, 2013 | 145.20M | 88.08% |
Dec 31, 2012 | 77.20M | 110.93% |
Dec 30, 2011 | 36.60M | -34.76% |
Dec 31, 2010 | 56.10M | 22.22% |
Dec 31, 2009 | 45.90M | 237.50% |
Dec 31, 2008 | 13.60M | -87.36% |
Dec 31, 2007 | 107.60M | 2,239.13% |
Dec 29, 2006 | 4.60M | 142.11% |
Dec 30, 2005 | 1.90M | 137.50% |
Dec 31, 2004 | 800.00K | -80.95% |
Dec 31, 2003 | 4.20M | 55.56% |
Dec 31, 2002 | 2.70M | -96.82% |
Dec 31, 2001 | 84.90M | - |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 814.94B |
Novo Nordisk | 579.91B |
UnitedHealth Group | 520.32B |
Johnson & Johnson | 372.29B |
Merck & Co. | 318.55B |
AbbVie | 304.29B |
AstraZeneca | 244.04B |
Novartis AG | 207.64B |